Listing & Compliance Notices

Adagio Medical Holdings, Inc. received a nasdaq noncompliance notice notice regarding audit committee (rules 5605(c)(2)(A)).

“December 20, 2024, Adagio Medical Holdings, Inc., a Delaware corporation (the “Company”), notified the Nasdaq Stock Market LLC (“Nasdaq”) that the Company will not be in compliance with the audit committee requirement under Nasdaq Listing Rule 5605(c)(2)(A) as of January 1, 2025, solely due to a vacancy on the audit committee (the “Audit Committee”) of the Company’s Board of Directors (the “Board”) resulting from Shahram Moaddeb’s resignation from the Board as disclosed in”

COMTECH TELECOMMUNICATIONS CORP /DE/ received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“December 18, 2024, Comtech Telecommunications Corp. (“Comtech” or the “Company”) received a letter (the “Letter”) from the Nasdaq Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that it is not in compliance with periodic requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) because the Company’s Quarterly Report on Form 10-Q for the period ended October 31, 2024 (the “Report”) was not filed with the Securities and Exchange Commission (the “SEC”) by the required extended due date of December 16, 2024. Th”

CLEARONE INC received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“ket (“Nasdaq”) notifying the Company that, because the closing bid price for its common stock had been below $1.00 per share for 30 consecutive business days, it is no longer in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed companies to maintain a minimum bid price of $1.00 per share (the “Minimum Bid Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided 180 days, or until December 17, 2024, to regain compliance with the Minimum Bid Requirement. On Dece”

Hyperscale Data, Inc. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(ii), 1003(a)(iii)).

“December 18, 2024, the Company was notified by the NYSE American that due to the Company’s disclosure in its Form 10-Q filed for the fiscal period ended September 30, 2024, which reported stockholders’ equity of approximately $2.2 million, it no longer meets the requirement that it must have no less than $6 million or more in stockholders’ equity pursuant to the listing standard set forth under Section 1003(a)(ii) and (iii) of the NYSE American Company Guide (the “ Listing Standards ”) because the Company has reported losses from continuing operations and/or net losses in five of its most rece”

CUMULUS MEDIA INC received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“December 16, 2024, Cumulus Media Inc. (the “Company”) received a notification from the Listing Qualifications Department of The NASDAQ Stock Market LLC (“NASDAQ”) indicating that the Company is not in compliance with NASDAQ Listing Rule 5550(a)(2) (the “Rule”) because the bid price of the Company’s Class A common stock on The Nasdaq Global Market has closed below $1.00 per share for 30 consecutive business days. The NASDAQ letter has no immediate effect on the NASDAQ listing or trading of the Company’s Class A common stock. In accordance with NASDAQ Listing Rule 5810(c)(3)(A), the Company has”

AMERICAN BATTERY TECHNOLOGY Co received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5550(a)(2), 5810(c)(3)(A)).

“December 19, 2024, American Battery Technology Company (the “Company”) received written notice (the “Notification Letter”) from the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5450(a)(1) for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(a)(2) requires listed securities maintain a minimum closing bid price of $1.00 per share, and Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum closing bid price requirement exists if the deficiency c”

Sports Entertainment Gaming Global Corp received a nasdaq compliance regained notice regarding late filing (rules 5250(c)(1)).

“December 20, 2024, Lottery.com received a letter from Nasdaq indicating that, as a result of the December 16, 2024 filing of its Form 10-Q for the period ended September 30, 2024 with the SEC, the Company is in compliance with the Listing Rule. Nasdaq has closed the matter. Forward Looking Statements This Current Report on Form 8-K (the “Form 8-K”) contains statements that constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements o”

QT IMAGING HOLDINGS, INC. received a nasdaq delisting notice notice regarding market value (rules 5450(b)(2)(A)).

“November 6, 2024 that it had determined to commence proceedings to delist the Common Stock from the Nasdaq Global Select Market (the “Nasdaq”) due to its determination that the Company’s common stock is no longer suitable for listing because the Company’s market value of is listed securities fell below the minimum $50,000,000 required for continued listing as set forth in Rule 5450(b)(2)(A) (the “MVLS Rule”) and the Company was unable to regain compliance with the MVLS Rule by November 4, 2024. The Company proceeded to initiate an appeal of the Staff’s determination to commence delisting of th”

QT IMAGING HOLDINGS, INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“December 17, 2024, the Staff formally notified the Company that it was unable to regain compliance with the Price Rule during the provided 180-day compliance window, which the Staff considers an additional basis for delisting the Company’s Common Stock from the Nasdaq and which will be considered in the Panel’s rendering of a decision on the Company’s appeal. If the Company’s appeal is unsuccessful, it is expected that the Common Stock would be delisted from the Nasdaq, in which case, the Company may apply to list on a different listing tier of the Nasdaq Global Stock Market or apply to list t”

Pinstripes Holdings, Inc. received a nyse delisting notice notice regarding minimum bid price (rules 802.01D).

“A common stock, par value $0.0001 per share (the “Class A Common Stock”), at an exercise price of $11.50 per share, and listed to trade on the NYSE under the symbol “PNST.WS” and (b) immediately suspend trading of the Public Warrants due to “abnormally low” trading price levels pursuant to Section 802.01D of the NYSE Listed Company Manual. Trading in the Company’s Class A Common Stock will be unaffected and will continue on the NYSE under the symbol “PNST,” subject to the Company's continued compliance with the NYSE's other continued listing requirements. SIGNATURES Pursuant to the requiremen”

Alpha Star Acquisition Corp received a nasdaq delisting notice notice regarding other (rules IM-5101-2).

“ants will be suspended at the opening of business on December 23, 2024; and (iii) a Form 25-NSE will be filed with the Securities and Exchange Commission (the “SEC”), which will remove the Company’s securities from listing and registration on The Nasdaq Stock Market. Pursuant to Nasdaq Listing Rule IM-5101-2, a special purpose acquisition company must complete one or more business combinations within 36 months of the effectiveness of its IPO registration statement. Since the Company failed to complete its initial business combination by December 13, 2024, the Company did not comply with IM-510”

Stran & Company, Inc. received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).

“December 17, 2024, Stran & Company, Inc., a Nevada corporation (the “Company”), received a letter from the Listing Qualifications staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”), issuing a Staff delisting determination (the “Staff Determination”). The Staff Determination noted that the Staff had notified the Company on June 21, 2024, August 23, 2024, and November 21, 2024, that the Company did not comply with Nasdaq Listing Rule 5250(c)(1) (the “Filing Rule”) because the Company had not filed its Quarterly Reports on Forms 10-Q for the periods ended March 31, 2024, June 30, 2024”

CDT Equity Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)(iii)).

“December 17, 2024, Nasdaq issued a letter to the Company that as of December 17, 2024, it determined that the Company’s securities had a closing bid price of $0.10 or less for ten consecutive trading days. Accordingly, the Company is subject to the provisions contemplated under Listing Rule 5810(c)(3)(A)(iii) (the “Low Priced Stocks Rule” together with the Rule, the “Rules”). As a result, unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “Panel”), Nasdaq has determined to delist the Company’s securities from The Nasdaq Stock Market on December 27, 2024. Accordi”

Molecular Templates, Inc. received a nasdaq delisting notice notice regarding other (rules 5101, 5250(c)(1)).

“December 16, 2024, Molecular Templates, Inc. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon Nasdaq’s review of the Company and pursuant to Nasdaq Listing Rule 5101, Nasdaq believes that the Company is a “public shell,” and that the continued listing of the Company’s securities is no longer warranted. Unless the Company timely requests an appeal, trading of the Company’s common stock will be suspended from trading on the Nasdaq Stock Market at the opening o”

Oncology Institute, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“December 19, 2024 (the “Second Nasdaq Bid Price Letter”), Nasdaq notified the Company that Nasdaq’s Staff has determined that the Company is eligible for an additional 180 calendar day period, or until June 16, 2025, to regain compliance (the “Second Compliance Period”). The determination is based on the Company’s meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on The Nasdaq Capital Market with the exception of the Minimum Bid Price Requirement, and the Company’s written notice of its intention to cure”

ConnectM Technology Solutions, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C)).

“December 13, 2024, ConnectM Technology Solutions, Inc., a Delaware corporation (the " Company "), received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC (" Nasdaq ") indicating that based upon Nasdaq’s review of the Company’s Market Value of Publicly Held Shares (MVPHS) for the 33 consecutive business days prior to the date of the letter, the Company no longer meets the requirements of Nasdaq Listing Rule 5450(b)(2)(C), which requires listed securities to maintain a minimum MVPHS of $15,000,000. However, Nasdaq rules also provide the Company a”

Dragonfly Energy Holdings Corp. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

“December 12, 2024, Dragonfly Energy Holdings Corp. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(2), which requires the Company to maintain a minimum Market Value of Listed Securities (“MVLS”) of $35 million for continued listing on The Nasdaq Capital Market (the “MVLS Requirement”) for the 30 consecutive business days preceding receipt of the Notice. Additionally, as of the date of this Current Report, the Company doe”

Kairous Acquisition Corp. Ltd received a nasdaq delisting notice notice regarding other (rules IM-5101-2).

“December 16, 2024 from the Nasdaq Stock Market LLC (“Nasdaq”), stating that the Company did not comply with Nasdaq Interpretive Material IM-5101-2, and that its securities are now subject to delisting. The Company’s registration statement, filed in connection with the Company’s IPO, became effective on December 13, 2021. Pursuant to IM-5101-2, the Company, a special purpose acquisition company, must complete one or more business combinations within 36 months of the effectiveness of its IPO registration statement. Since the Company did not complete its initial business combination by December 1”

INSPIRE VETERINARY PARTNERS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“December 16, 2024 , the Company received a letter from the Staff notifying the Company that, based upon the closing bid price of the Company’s common stock, par value $0.0001 per share, for the prior 30 consecutive business days, the Company was not in compliance with the minimum bid price requirement of Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided a grace period of 180 days, or until June 16, 2025, to regain compliance with the Minimum Bid Price Requirement. 1 SIGNATURES Pursuant to the req”

VACCINEX, INC. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).

“December 16, 2024, Vaccinex, Inc. (the “Company”) received written notice (the “Notice”) from the Office of General Counsel of The Nasdaq Stock Market (“Nasdaq”) indicating that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the Company’s shares from Nasdaq due to the Company’s failure to meet Nasdaq’s continued listing standards. As previously disclosed, the Company has not been compliant with the requirements under Nasdaq Listing Rule 5550(b)(1) to maintain a minimum of $2.5 million in stockholders’ equity for continued listing on the Nasdaq Capital Market. The Notice indic”

22nd Century Group, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5810(c)(3)(A)(iii), 5550(a)(2)).

“December 16, 2024, the Company received a letter from Nasdaq notifying the Company that, as of December 13, 2024, the common stock had a closing bid price of $0.10 or less for 10 consecutive trading days. Accordingly, the Company is subject to the provisions of Listing Rule 5810(c)(3)(A)(iii) (the “Low Priced Stocks Rule”). As a result, Nasdaq has determined to delist the Company’s securities from The Nasdaq Capital Market, notwithstanding the Bid Price Cure Period, which is rendered unavailable by the Low Priced Stocks Rule. The Company has the right to appeal Nasdaq’s determination by Decemb”

ATECH (PARENT) RESOLUTION CORP. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“December 17, 2024, Akoustis Technologies, Inc. (the “Company”) received written notice (the “Notice”) from the Office of General Counsel of The Nasdaq Stock Market (“Nasdaq”) indicating that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the Company’s shares from Nasdaq due to the Company’s failure to meet Nasdaq’s continued listing standards. As previously disclosed, the Company has not been compliant with the requirement under Nasdaq Listing Rule 5550(a)(2) to maintain a minimum bid price of $1.00 for continued listing on the Nasdaq Capital Market. Additionally, the Notice”

Medalist Diversified, Inc. received a nasdaq delisting notice notice regarding other (rules 5555(a)(3)).

“ket LLC (“ Nasdaq ”) notifying the Company that, based on the Company’s Current Report on Form 8-K filed on October 23, 2024, its 8.0% Series A Cumulative Redeemable Preferred Stock (the “ Preferred Stock ”) no longer meets the minimum 100,000 publicly held shares requirement of Nasdaq Listing Rule 5555(a)(3) for continued listing on The Nasdaq Capital Market. ​ The Nasdaq Letter has no immediate effect on the listing of the Preferred Stock, which will continue to trade under the symbol “MDRRP,” subject to the Company’s compliance with the other continued listing requirements of Nasdaq. In acc”

Medalist Diversified, Inc. received a nasdaq noncompliance notice notice regarding other (rules 5555(a)(3)).

“December 11, 2024, the Company received a letter (the “ Nasdaq Letter ”) from the Listing Qualification Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that, based on the Company’s Current Report on Form 8-K filed on October 23, 2024, its 8.0% Series A Cumulative Redeemable Preferred Stock (the “ Preferred Stock ”) no longer meets the minimum 100,000 publicly held shares requirement of Nasdaq Listing Rule 5555(a)(3) for continued listing on The Nasdaq Capital Market. ​ The Nasdaq Letter has no immediate effect on the listing of the Preferred Stock, which will conti”

Digital Brands Group, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5550(b)(1), 5635).

“December 16, 2024, The Nasdaq Stock Market LLC (“Nasdaq”) notified Digital Brands Group, Inc., a Delaware corporation (the “Company”), that the Nasdaq Hearings Panel (the “Panel”) has determined to delist the Company’s common stock and that trading of the Company’s securities will be suspended at the open of trading on December 18, 2024. The Company expects its common stock will be eligible for quotation on the OTC Pink Market under its existing symbol, “DBGI”. The Panel reached its decision because the Company is in violation of Listing Rules 5550(a)(2), 5550(b)(1), and 5635, the Bid Price, S”

ATIF Holdings Ltd received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b), 5810(b)).

“December 12, 2024, ATIF Holdings Limited (the “ Company ”) received a notice from The Nasdaq Stock Market LLC (“ Nasdaq ”) Listing Qualifications Staff (the “ Staff ”) stating that the Staff has determined, unless the Company timely requests an appeal of the Staff’s determination, before Nasdaq’s Hearing Panel (the “ Panel ”), by December 19, 2024, to delist the Company’s ordinary shares from the Nasdaq Capital Market because the Company is not in compliance with the minimum $2,500,000 stockholders’ equity requirement for continued listing set forth in the Nasdaq Listing Rule 5550(b) as report”

Perfect Moment Ltd. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(ii)).

“December 11, 2024, Perfect Moment Ltd. (the “Company”) received a notification (“Letter”) from the NYSE American LLC (the “NYSE American”) stating that the Company is not in compliance with the minimum stockholders’ equity requirements of Sections 1003(a)(ii) of the NYSE American Company Guide (the “Company Guide”) requiring stockholders’ equity of $4.0 million or more if the Company has reported losses from continuing operations and/or net losses in three of the four most recent fiscal years. As of September 30, 2024, the Company had stockholders’ equity of $2.7 million and has had losses in”

Blaize Holdings, Inc. received a nasdaq delisting notice notice regarding other (rules IM-5101-2).

“December 11, 2024, BurTech Acquisition Corp. (the “Company”) received a notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”), stating that the Company did not comply with Nasdaq Interpretive Material IM-5101-2 (“IM-5101-2”), and that its securities are now subject to delisting. Pursuant to IM-5101-2, the Company, a special purpose acquisition company, must complete one or more business combinations within 36 months of the effectiveness of its IPO registration statement. Since the Company did not complete its initial business combination by December 10, 2024, the Company did not co”

Integrated Wellness Acquisition Corp received a nyse delisting notice notice regarding other.

“December 13, 2024, Integrated Wellness Acquisition Corp (the “ Company ”) received written notice from the New York Stock Exchange (the “ NYSE ”) indicating that the staff of NYSE Regulation had determined to commence proceedings to delist the Company’s securities from the NYSE due to the Company’s failure to consummate a business combination within the shorter of (i) the time period specified by its constitutive documents or by contract or (ii) three years following the closing of the Company’s initial public offering. Trading in the Company’s securities was suspended immediately after market”

AIM ImmunoTech Inc. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(ii), 1003(a)(iii)).

“losses from continuing operations and/or net losses in its five most recent fiscal years, respectively. As of September 30, 2024, the Company had a stockholders’ deficit of $2.9 million and has had losses in the most recent five fiscal years ended December 31, 2023. The Company is now subject to the procedures and requirements of Section 1009 of the Company”

OLENOX INDUSTRIES INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“December 12, 2024, Safe & Green Holdings Corp. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that for the preceding 30 consecutive business days (October 30, 2024 through December 11, 2024), the Company’s common stock did not maintain a minimum closing bid price of $1.00 per share (the “Minimum Bid Price Requirement”) as required by Nasdaq Listing Rule 5550(a)(2). The notice has no immediate effect on the listing or trading of the Company’s common stock and the common stock will continue to trade on”

DBV Technologies S.A. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).

“December 13, 2024, DBV Technologies S.A. (the “Company”) received a letter from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Staff has determined that the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2). The Staff determined that for 10 consecutive business days, from November 29, 2024 to December 12, 2024, the closing bid price of the Company’s American Depositary Shares has been at $1.00 per share or greater. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the regist”

iLearningEngines, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“December 4, 2024, iLearningEngines , Inc. (the “ Company ”) received a delinquency notification letter (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that due to the delay in filing the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 (the “ Form 10-Q ”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “ Rule ”), which requires listed companies to timely file all periodic financial reports with the Securities and Exchange Commission (the “ SEC ”). The Notice”

Target Global Acquisition I Corp. received a nasdaq delisting notice notice regarding other (rules IM-5101-2).

“December 10, 2024, Target Global Acquisition I Corp., a Cayman Islands exempted company (the “Company”), received a notice (the “Delisting Notice”) from the staff of the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) stating that Nasdaq has determined to delist the Company’s securities on The Nasdaq Global Market and will suspend trading in the Company’s securities effective as of the opening of business on December 17, 2024, due to the Company’s non-compliance with Nasdaq IM-5101-2, which requires that a special purpose acquisition company complete one or more busines”

IX Acquisition Corp. received a nasdaq delisting notice notice regarding other.

“December 10, 2024, IX Acquisition Corp. (the “ Company ”) received a notice from the Nasdaq Listing Qualifications Hearings (“ Panel ”) acknowledging that the Company had withdrawn its appeal of the October 7, 2024 delist determination issued by the Nasdaq Listings Qualifications Staff (“ Nasdaq ”). Accordingly, trading in the Company’s securities was suspended at the open of trading on December 12, 2024. Nasdaq will file a Form 25 Notification of Delisting with the U.S. Securities and Exchange Commission. When the Company’s securities are delisted from Nasdaq, its securities are expected to t”

APx Acquisition Corp. I received a nasdaq delisting notice notice regarding other (rules IM-5101-2).

“December 17, 2024 and (iii) a Form 25-NSE will be filed with the Securities and Exchange Commission (the “SEC”), which will remove the Company’s securities from listing and registration on Nasdaq. Under Rule IM-5101-2, a special purpose acquisition company must complete one or more business combinations within 36 months of the effectiveness of its initial public offering registration statement. Since the Company failed to complete its initial business combination by December 6, 2024, the Staff concluded that the Company did not comply with Rule IM-5101-2 and that the Company’s securities are n”

Technology & Telecommunication Acquisition Corp received a nasdaq deficiency notice notice regarding other (rules 5620(a), 5810(c)(2)(G)).

“December 9, 2024, Technology & Telecommunication Acquisition Corporation (the “Company”), received a notification letter from the Listing Qualifications Staff of The NASDAQ Stock Market LLC (“Nasdaq”) indicating that, since the Company has not yet held an annual meeting of shareholders within twelve months of the end of its fiscal year, it is out of compliance with the Nasdaq rules for continued listing (Listing Rules 5620(a) and 5810(c)(2)(G)). The notification letter has no immediate effect on the listing of the Company’s securities on the Nasdaq Global Market. Under the applicable Nasdaq ru”

BIO-PATH HOLDINGS, INC. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“December 12, 2024, Bio-Path Holdings, Inc. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the last 30 consecutive business days, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar day”

T2 Biosystems, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5550(b)(2)).

“November 7, 2024, the Company received a separate letter from Nasdaq indicating that the Company’s market value of its listed securities has been below the minimum $35,000,000 required for continued listing on the Nasdaq Capital Market, as set forth in Listing Rule 5550(b)(2) for the previous thirty consecutive trading days. In accordance with the terms of the previously imposed “Mandatory Panel Monitor” as that term is defined in Nasdaq Listing Rule 5815(d)(4)(B), the Nasdaq Listing Qualifications Staff (the “Staff”) did not grant the Company a grace period but rather issued a delist determin”

T2 Biosystems, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“December 12, 2024, the Company received a letter from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last thirty consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). As previously disclosed, on November 7, 2024, the Company received a separate letter from Nasdaq indicating that the Company’s market value of its listed securities has been below the minimum $35,000,000 required for continued listing on the Nasdaq Cap”

HYPERION DEFI, INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iii)).

“December 12, 2024, the Company received a letter from Nasdaq notifying the Company that, as of December 11, 2024, the common stock had a closing bid price of $0.10 or less for 10 consecutive trading days. Accordingly, the Company is subject to the provisions of Listing Rule 5810(c)(3)(A)(iii) (the “Low Priced Stocks Rule”). As a result, Nasdaq has determined to delist the Company’s securities from The Nasdaq Capital Market, notwithstanding the Bid Price Cure Period, which is rendered unavailable by the Low Priced Stocks Rule. The Company has the right to appeal Nasdaq’s determination by Decemb”

Equillium, Inc. received a nasdaq noncompliance notice notice regarding minimum bid price (rules 5550(a)(2)).

“December 13, 2024, Equillium, Inc. (the “Company”) received a notice from The Nasdaq Stock Market (“Nasdaq”) that the Company is not in compliance with Nasdaq’s Listing Rule 5550(a)(2), as the minimum bid price of the Company’s common stock has been below $1.00 per share for 30 consecutive business days (the “Minimum Bid Price Requirement”). The notification of noncompliance has no immediate effect on the listing or trading of the Company’s common stock on The Nasdaq Capital Market and the Company’s common stock continues to trade on the Nasdaq Capital Market under the symbol “EQ.” Under Nasda”

Perception Capital Corp. III received a nasdaq delisting notice notice regarding other (rules IM-5101-2, 5505).

“December 5, 2024, Perception Capital Corp. III (the “Company”) received a notice that the Nasdaq Hearings Panel has determined to delist the Company’s Class A Ordinary Shares, units, and warrants from The Nasdaq Stock Market (“Nasdaq”) due to its failure to comply with the terms of the Panel decision dated September 17, 2024 (the “Decision”), and that trading in the Company’s securities will be suspended at the open of trading on December 9, 2024. The Decision had granted the Company’s request for an exception to Nasdaq IM-5101-2, which requires that a special purpose acquisition company compl”

ConnectM Technology Solutions, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“December 6, 2024, ConnectM Technology Solutions, Inc. (“ ConnectM ” or the “ Company ”) received a notice from the staff of the Listing Qualifications Department of Nasdaq stating that because the Company had not filed its Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the “ Filing ”), it no longer complies with Nasdaq Listing Rule 5250(c)(1) for continued listing, which requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the “ SEC ”). This notification has no immediate effect on the listing of th”

Bio Green Med Solution, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“December 6, 2024, Cyclacel Pharmaceuticals, Inc. (the “Company”) received a written notice from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, based upon the closing bid price of the Company’s common stock, par value $0.001 per share, (the “Common Stock”) for the last 30 consecutive business days, the Common Stock did not meet the minimum bid price of $1.00 per share required by Nasdaq Listing Rule 5550(a)(2), initiating an automatic 180 calendar-day grace period for the Company to regain compliance. The notice has no immediate effect on the listing or trading of the Compan”

Onconetix, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“December 6, 2024, Onconetix, Inc. (the “Company”) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC informing the Company that, as a result of not having timely filed its Quarterly Report on Form 10-Q for the period ended September 30, 2024 (the “Form 10-Q”) with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all required periodic financial reports with the SEC. On December 10, 2024, the Company filed its Form 10-Q with the SEC. This Cur”

SOCIETY PASS INCORPORATED. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“December 6, 2024, Society Pass Incorporated (the “Company”) received a letter (the “Nasdaq Staff Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, for the last thirty (30) consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has been provided an initial period of 180 calendar days, or until June 4, 2025, to regain compliance. The letter states tha”

Healthcare AI Acquisition Corp. received a nasdaq deficiency notice notice regarding other (rules IM-5101-2).

“December 10, 2024 Healthcare AI Acquisition Corp. (the “ Company ”) received a notice (the “ Notice ”) from the Nasdaq Stock Market LLC (“ Nasdaq ”), stating that the Company did not comply with Nasdaq Interpretive Material IM-5101-2, and that its securities are now subject to delisting. The Company’s registration statement, filed in connection with the Company’s IPO, became effective on December 09, 2021. Pursuant to IM-5101-2, the Company, a special purpose acquisition company, must complete one or more business combinations within 36 months of the effectiveness of its IPO registration state”

Profusa, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“any is working diligently to complete its Form 10-Q for the period ended September 30, 2024. and expects to file its Form 10-Q within the 60-day period described above, which would eliminate the need for the Company to submit a formal plan to regain compliance. As required under Nasdaq Listing Rule 5810(b), the Company issued a press release on December 11, 2024, announcing that it had received the Notice. A copy of this press release is attached as Exhibit 99.1 to this Form 8-K. 1”

Athena Technology Acquisition Corp. II received a nasdaq delisting notice notice regarding other.

“December 10, 2024, Athena Technology Acquisition Corp. II (the “ Company ”) received a letter from the NYSE American LLC (“ NYSE American ” or the “ Exchange ”) stating that the staff of NYSE Regulation has determined to commence proceedings to delist the Company’s (i) class A Common Stock, par value $0.0001 per share (the “ Class A Common Stock ”), (ii) units, each consisting of one share of Class A Common Stock and one-half of one redeemable warrant (“ Units ), and (iii) redeemable warrants, each whole warrant exercisable for one share of Class A Common Stock, each at an exercise price of $1”